The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 15, 2016

Filed:

Mar. 15, 2013
Applicant:

University of Vermont, Burlington, VT (US);

Inventor:

Peter S. Spector, Burlington, VT (US);

Assignee:

University of Vermont, Burlington, VT (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 5/04 (2006.01); A61B 5/042 (2006.01); A61B 5/046 (2006.01); A61B 19/00 (2006.01);
U.S. Cl.
CPC ...
A61B 5/04014 (2013.01); A61B 5/046 (2013.01); A61B 5/04017 (2013.01); A61B 5/0422 (2013.01); A61B 18/14 (2013.01); A61B 18/1492 (2013.01); A61B 19/5244 (2013.01); A61B 2019/5251 (2013.01); A61B 2562/046 (2013.01);
Abstract

Methods and systems for optimizing lesion placement to treat cardiac fibrillation in a patient include obtaining a map of one or more measurements indicative of a number and distribution of electrical circuit cores for a duration across a cardiac tissue substrate in response to electrical activity in the cardiac tissue substrate, identifying at least one region for the duration of the cardiac tissue substrate having a number of electrical circuit cores that is higher than a predetermined density threshold, generating a first sample set of lesions, the first sample set of lesions being registered onto the map, calculating and comparing a first total length of the first sample set of lesions to a predetermined length threshold, determining fitness of the first sample set of lesions, wherein fitness criteria is indicative of the level to which the sample set can terminate or at least minimize cardiac fibrillation.


Find Patent Forward Citations

Loading…